Johnson & Johnson (NYSE:JNJ)

145.72
Delayed Data
As of Sep 25
 +1.05 / +0.73%
Today’s Change
109.16
Today|||52-Week Range
157.00
-0.10%
Year-to-Date
US Indexes Close Higher Friday
7:35am / GuruFocus News - Paid Partner Content
Nasdaq Jumps Despite Costco Pullback; Novavax Starts Vaccine Phase 3 Trial
Sep 25 / MotleyFool.com - Paid Partner Content
Forget Apple: Here Are 3 Better Dividend Stocks
7:29am / MotleyFool.com - Paid Partner Content
3 Health Care Companies to Consider as Covid-19 Vaccine Trials Continue
Sep 25 / GuruFocus News - Paid Partner Content
3 Stocks to Help You Build Retirement Wealth
Sep 26 / MotleyFool.com - Paid Partner Content
3 Dividend Aristocrats to Buy and Hold Forever
Sep 25 / MotleyFool.com - Paid Partner Content
4 Reasons AbbVie Is More Attractive Than You Think
Sep 26 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: J&J's Coronavirus Vaccine in Phase III, Other Updates
Sep 24 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: JNJ, Pfizer, AstraZeneca, Sanofi and GSK
Sep 25 / Zacks.com - Paid Partner Content
Company News for Sep 24, 2020
Sep 24 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close144.67
Today’s open144.07
Day’s range144.02 - 146.25
Volume5,531,209
Average volume (3 months)6,534,705
Market cap$383.5B
Data as of 4:45pm ET, 09/25/2020

Growth & Valuation

Earnings growth (last year)+0.28%
Earnings growth (this year)-9.43%
Earnings growth (next 5 years)+5.75%
Revenue growth (last year)+0.71%
P/E ratio25.6
Price/Sales4.76
Price/Book6.45

Competitors

 Today’s
change
Today’s
% change
MRKMerck-0.19-0.23%
PFEPfizer+0.29+0.81%
NVSNovartis+0.81+0.94%
ABBVAbbVie+0.31+0.36%
Data as of 5:19pm ET, 09/25/2020

Financials

Next reporting dateOctober 13, 2020
EPS forecast (this quarter)$1.96
Annual revenue (last year)$82.1B
Annual profit (last year)$15.1B
Net profit margin18.41%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New Brunswick, New Jersey

Forecasts